Course Description: Alcohol-based hand sanitizer is an important element in infection prevention, especially during the COVID-19 pandemic. However, when quality is compromised, it can be less effective against infection transmission and can also lead to user harm. COVID-19-related supply chain pressures have created global shortages that led to new vendors, materials, and production pathways to meet demand. These fast-paced changes have caused an emergence of quality incidents both regionally and globally. Globally, over 200 alcohol-based hand sanitizer quality incidents have been reported in 2020. Specifically, in the United States, approximately 80 alcohol-based hand sanitizer quality incidents were reported in 2020.
Presenters from USP, U.S. FDA, healthcare provider groups, and public health institutions discuss the global and regional quality risks and solutions when compounding alcohol-based hand sanitizer, including:
- Global quality challenges and public health impact of alcohol-based hand sanitizers from compounding regulations to clinical perspectives on the frontline treating consequences from subquality products
- Regional regulatory and public health strategies to increase trust in alcohol-based hand sanitizers
- Standards and mitigation strategies for the compounding, labeling, packaging, storage, transportation, and distribution of alcohol-based hand sanitizer
- Compounding professionals’ perspectives and best practices from clinical peers’ sharing insights on quality in action
Who should attend:
- Compounders who are making alcohol-based hand sanitizers
- Regulatory agencies who support compounders
- Other interested healthcare provider groups or public health institutions